Skip to content

Frederiek Adams

Partner

Brussels

Image of Frederiek Adams
Frederiek Adams

Partner

Brussels

Frederiek is a corporate partner with more than 15 years of experience advising Belgian and international corporate clients and private equity investors. His focus is on cross-border and domestic M&A, joint ventures and equity capital market transactions.

He has represented a large number of local and international clients on both sell and buy-side transactions across a wide range of sectors, such as life sciences and healthcare, (renewable) energy, technology & software and manufacturing and chemicals.

Since more than five years Frederiek is recognized by all major legal directories receiving excellent client feedback “very pragmatic, sharp, pleasant and efficient” (Chambers Global 2022), “dynamic, smart, commercial and pleasant lawyer able to run transactions in a remarkably efficient manner” (Legal 500).

Related articles

Skyscraper city scape at night

Publications: 04 April 2023

Belgian summer brings foreign direct investment screening regime to Belgium

For many years, Belgium was one of the few EU Member States that did not have a national foreign direct investment (FDI) screening mechanism in place, but this is about to change.

Read more Belgian summer brings foreign direct investment screening regime to Belgium

Publications: 07 July 2022

What protections are available to investors on minority deals?

Read more What protections are available to investors on minority deals?

Publications: 04 January 2021

Looking ahead: What can 2021 bring for screening foreign direct investments in Belgium?

Read more Looking ahead: What can 2021 bring for screening foreign direct investments in Belgium?

Experience highlights

Office

Brussels

Tervurenlaan 268A avenue de Tervueren
Brussels
1150

View office →

Qualifications

Professional

Admitted to the Brussels Bar, Belgium, 2006

Academic

Master, Law, Katholieke Universiteit Leuven (KUL), 2005 

LLM, Oxford University, 2006

Other noteworthy experience

Advising:

  • IK Investment Partners on its sale of Vemedia, a Dutch OTC drugs company, creating a pan-European OTC group with sales of around EUR400m.
  • A division of a real estate investment trust company on the auction sale of a portfolio of 24 European logistics real estate assets to Blackstone Property Partners Europe.
  • Ergon Capital Partners on its investment in and sale of De Boeck Education and De Boeck Digital.
  • Gilde Buy Out Partners on its acquisition of t-groep, a Belgium-based cross-border human resource solutions provider from the Flemish Government.
  • Sumitomo Corporation on its investment in and disposal of various offshore wind parks in the Belgian North Sea.
  • Crelan on its highly competitive auction sale of Keytrade, Crelan’s internet bank and broker active in Belgium, Luxembourg and Switzerland.
  • Omega Pharma on its EUR470m acquisition of a portfolio of leading OTC brands from GlaxoSmithKline.
  • Selligent on its recapitalisation as a result of which California based private equity firm HGGC acquired a majority stake.
  • Campbell Soup Company on the EUR400m sale of its business in Europe including four plants.
  • Baltisse, the family office of Mr Balcaen (former owner of Balta and IVC) on its participation (alongside Waterland) in a private capital increase combined with a public rights issue for an aggregate amount of EUR220m.

Recognition